+
Site Tour

bRIGHT 2-year real-world outcomes, presented by R. Bekeredjian

bRIGHT results support the exceptional safety and effectiveness of TriClip TEER in real-world population at 2 years

Download

LEARN MORE:

EuroPCR Symposium 2025 TriClip

Related Resources

Poster: Primary MR in the Very Elderly

Prognosis of TR after MitraClip for MR

TRILUMINATE Pivotal - 2-year update EuroPCR 25

Tendyne expanded clinical study | PCR LV 2025

EXPAND G4 clinical data release | PCR LV 2025

bRIGHT clinical data release | PCR LV 2025

The standard of caring for TR

TEER G5 Brochure
2025

TRENDING TOPICS

bRIGHT clinical data release | PCR LV 2025

bRIGHT procedural clipping strategy presented at PCR LV 2025 by X. Freixa

Tendyne expanded clinical study | PCR LV 2025

5-year outcomes of TMVR for severe symptomatic mitral regurgitation presented at PCR LV 2025 by A. Duncan

EXPAND G4 clinical data release | PCR LV 2025

2-year outcomes from the EXPAND G4 study presented at PCR LV 2025 by F. De Marco

CONNEXT


TV
RELATED RESOURCES

The Standard of Caring For TR

TAVI strategies for patient lifetime management

TriClip Symposium | PCR LV 2025

bRIGHT interview with X. Freixa | PCR LV 2025

CONNEXT


LIVE
RELATED EVENTS

TAVI webinar - key learnings in TAVI

Review the Trends | Tricuspid Focus

Debates and Controversies | Mitral Focus

Case Parade | Mitral Focus

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline